| Title： | Chinese Guidelines for diagnosis and treatment of BCG adverse reactions |
| Edition： | Original |
| Classification： | Standard guideline |
| Field： | Comprehensive guideline |
| Countries and regions： | China |
| Guidelines users： | Paediatrics, infectious diseases, tuberculosis, urology, oncology and transplantation doctors, public health workers and related nursing staff. |
| Evidence classification method： | GRADE |
| Development unit： | 中华医学会结核病学分会、中国防痨协会学校与儿童结核分会、深圳市第三人民医院 |
| Registration time: | 2022-03-08 |
| Registration number： | IPGRP-2022CN116 |
| Purpose of the guideline: | Adverse reactions occur from time to time after BCG inoculation and perfusion, but the clinical management of BCG adverse reactions has not been standardized at present, so this guide is formulated to guide medical staff to standardize and reasonably manage BCG adverse reactions. |
